BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

590 related articles for article (PubMed ID: 32208196)

  • 1. Acral Lentiginous Melanoma: Incidence and Survival in the United States, 2006-2015, an Analysis of the SEER Registry.
    Huang K; Fan J; Misra S
    J Surg Res; 2020 Jul; 251():329-339. PubMed ID: 32208196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acral lentiginous melanoma: incidence and survival patterns in the United States, 1986-2005.
    Bradford PT; Goldstein AM; McMaster ML; Tucker MA
    Arch Dermatol; 2009 Apr; 145(4):427-34. PubMed ID: 19380664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial differences in six major subtypes of melanoma: descriptive epidemiology.
    Wang Y; Zhao Y; Ma S
    BMC Cancer; 2016 Aug; 16(1):691. PubMed ID: 27576582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does sentinel lymph node status have prognostic significance in patients with acral lentiginous melanoma?
    Pavri SN; Han G; Khan S; Han D
    J Surg Oncol; 2019 Jun; 119(8):1060-1069. PubMed ID: 30883783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caucasians with acral lentiginous melanoma have the same outcome as patients with stage- and limb-matched superficial spreading melanoma.
    Susok L; Gambichler T
    J Cancer Res Clin Oncol; 2022 Feb; 148(2):497-502. PubMed ID: 33856527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acral lentiginous melanoma versus other melanoma: A single-center analysis in Japan.
    Wada M; Ito T; Tsuji G; Nakahara T; Hagihara A; Furue M; Uchi H
    J Dermatol; 2017 Aug; 44(8):932-938. PubMed ID: 28342269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acral lentiginous melanoma: Clinicopathologic and survival differences according to tumour location.
    Howard M; Xie C; Wee E; Wolfe R; McLean C; Kelly JW; Pan Y
    Australas J Dermatol; 2020 Nov; 61(4):312-317. PubMed ID: 32363586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of acral lentiginous histologic type in T1 melanoma.
    Mejbel HA; Torres-Cabala CA; Milton DR; Ivan D; Feldmeyer L; Namikawa K; Nagarajan P; Tetzlaff MT; Curry JL; Ross MI; Hwu WJ; Prieto VG; Aung PP
    Mod Pathol; 2021 Mar; 34(3):572-583. PubMed ID: 32759976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Gloves-and-socks" melanoma: does histology make a difference?
    Soudry E; Gutman H; Feinmesser M; Gutman R; Schachter J
    Dermatol Surg; 2008 Oct; 34(10):1372-8. PubMed ID: 18616532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethnic differences among patients with cutaneous melanoma.
    Cormier JN; Xing Y; Ding M; Lee JE; Mansfield PF; Gershenwald JE; Ross MI; Du XL
    Arch Intern Med; 2006 Sep; 166(17):1907-14. PubMed ID: 17000949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acral lentiginous melanoma: who benefits from sentinel lymph node biopsy?
    Ito T; Wada M; Nagae K; Nakano-Nakamura M; Nakahara T; Hagihara A; Furue M; Uchi H
    J Am Acad Dermatol; 2015 Jan; 72(1):71-7. PubMed ID: 25455840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features and prognosis of Asian patients with acral lentiginous melanoma who have nodal nevi in their sentinel lymph node biopsy specimen.
    Kim HJ; Seo JW; Roh MS; Lee JH; Song KH
    J Am Acad Dermatol; 2018 Oct; 79(4):706-713. PubMed ID: 29673774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acral lentiginous melanoma: a skin cancer with unfavourable prognostic features. A study of the German central malignant melanoma registry (CMMR) in 2050 patients.
    Teramoto Y; Keim U; Gesierich A; Schuler G; Fiedler E; Tüting T; Ulrich C; Wollina U; Hassel JC; Gutzmer R; Goerdt S; Zouboulis C; Leiter U; Eigentler TK; Garbe C
    Br J Dermatol; 2018 Feb; 178(2):443-451. PubMed ID: 28707317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial disparities in melanoma survival.
    Dawes SM; Tsai S; Gittleman H; Barnholtz-Sloan JS; Bordeaux JS
    J Am Acad Dermatol; 2016 Nov; 75(5):983-991. PubMed ID: 27476974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acral lentiginous melanoma incidence by sex, race, ethnicity, and stage in the United States, 2010-2019.
    Holman DM; King JB; White A; Singh SD; Lichtenfeld JL
    Prev Med; 2023 Oct; 175():107692. PubMed ID: 37659614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor infiltrating lymphocytes in acral lentiginous melanoma: a study of a large cohort of cases from Latin America.
    Castaneda CA; Torres-Cabala C; Castillo M; Villegas V; Casavilca S; Cano L; Sanchez J; Dunstan J; Calderon G; De La Cruz M; Cotrina JM; Gomez HL; Galvez R; Abugattas J
    Clin Transl Oncol; 2017 Dec; 19(12):1478-1488. PubMed ID: 28577153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between Race/Ethnicity and Survival of Melanoma Patients in the United States Over 3 Decades: A Secondary Analysis of SEER Data.
    Ward-Peterson M; Acuña JM; Alkhalifah MK; Nasiri AM; Al-Akeel ES; Alkhaldi TM; Dawari SA; Aldaham SA
    Medicine (Baltimore); 2016 Apr; 95(17):e3315. PubMed ID: 27124020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ongoing racial disparities in melanoma: An analysis of the Surveillance, Epidemiology, and End Results database (1975-2016).
    Qian Y; Johannet P; Sawyers A; Yu J; Osman I; Zhong J
    J Am Acad Dermatol; 2021 Jun; 84(6):1585-1593. PubMed ID: 32861710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acral lentiginous melanoma-Population, treatment, and survival using the NCDB from 2004 to 2015.
    Bian SX; Hwang L; Hwang J; Ragab O; In GK; Peng D; Lin E
    Pigment Cell Melanoma Res; 2021 Nov; 34(6):1049-1061. PubMed ID: 34273249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acral Lentiginous Melanoma Is Associated with Certain Poor Prognostic Histopathological Factors but May Not be Correlated with Nodal Involvement, Recurrence, and a Worse Survival.
    Tas F; Erturk K
    Pathobiology; 2018; 85(4):227-231. PubMed ID: 29860247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.